DIA
MRNA icon

Dana Investment Advisors’s Moderna MRNA Stock Holding History

Dana Investment Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,788
Closed -$331K – 547
2024
Q2 		$331K Sell
2,788
-8,661
-76% -$1.1M 0.01% 470
2024
Q1 		$1.22M Buy
11,449
+137
+1% +$13.8K 0.04% 356
2023
Q4 		$1.12M Buy
11,312
+7,453
+193% +$627K 0.05% 239
2023
Q3 		$399K Buy
3,859
+762
+25% +$85K 0.02% 338
2023
Q2 		$376K Buy
+3,097
New +$413K 0.02% 346

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dana Investment Advisors's MRNA Position: Q3 2024 in Review

Dana Investment Advisors sold out of Moderna (MRNA) in Q3 2024, closing a stake of 2,788 shares — an estimated $331K sold.

Dana Investment Advisors first reported a position in MRNA in Q2 2023 and held it in 5 quarters. The position peaked at $1.22M in Q1 2024. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • Dana Investment Advisors reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
  • Dana Investment Advisors sold 2,788 Moderna shares in Q3 2024, an estimated $331K.
  • Dana Investment Advisors first reported a position in Moderna in Q2 2023 and held it in 5 quarters.
  • Dana Investment Advisors's Moderna position peaked at $1.22M in Q1 2024.
  • 788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on Dana Investment Advisors's 13F filing for Q3 2024, filed 13 Nov 2024.